August 4, 2026
Background on Classification Under the DMPA
The rapid development of software and AI technologies has led to the emergence of digital medical devices with increasingly diverse and complex characteristics. Because these products may have multiple intended uses or evolve through software updates and AI learning processes, the conventional medical device classification system based on predefined intended uses has limitations in appropriately categorizing such products and identifying their associated risks. Therefore, a separate classification framework for digital medical devices was introduced.
Regulations on Product Code and Classification of Digital Medical Products
Under the DMPA, the manufacturer and/or importer should identify the appropriate product code and proposed classification based on detailed criteria regarding the regulations on classification and grading of digital medical products. A new seven alpha numeric product code is introduced for digital medical devices.
The product code and classification are finalized during the registration process. False or incorrect product codes or classification may result in a request for supplementary information or rejection during the review process.
This article focuses on product code identification.
Background on DMPA Product Code
Article 6, Paragraph 2, Annex 3 of the Regulations on Classification and Grading of Digital Medical Products describes the product code. Each digital medical product is assigned to a seven character product code based on the intended use, technology, and product form. In this product code, the first two characters represent the primary intended use, the following three characters represent the technology type, and the last two characters represent the form of the product.

The product code for a digital medical device product group is generated based on the characteristics of a representative product selected to represent the product group.
DMPA Product Code Intended Use
The first character of a digital medical device shall be assigned based on the primary intended use, and the second character shall be assigned based on the detailed characteristics of the products under each primary intended use.
Intended Use | First Character (Alphabet Capital) | Second Character (Number) |
A. Examination (Measurement, photography, etc.) | 1. Medical imaging | |
| 2. Bio-signals | ||
| 3. In vitro diagnostic indicators | ||
| 4. Others | ||
| 5. 2 or more | ||
B. Diagnosis (Medical judgment support, Diagnosis assistance, etc.) | 1. Medical imaging | |
| 2. Bio-signals | ||
| 3. In vitro diagnostic indicators | ||
| 4. Others | ||
| 5. 2 or more | ||
C. Treatment (Treatment or treatment assistance, etc.) | 1. Surgery or procedure (support) | |
| 2. Treatment plan and simulation | ||
| 3. Digital treatment device | ||
| 4. Others | ||
D. Clinical management guidance (Prediction, prevention, etc.) | 1. Medical imaging | |
| 2. Bio-signals | ||
| 3. In vitro diagnostic indicators | ||
| 4. Others | ||
| 5. 2 or more | ||
| E. Disability assistance and alleviation | 1. Exercise device | |
| 2. Function assistance | ||
| 3. Others | ||
F. Information provision and management (Monitoring) | 1. Medical imaging | |
| 2. Other | ||
| G. Pharmaceutical assistance | 1. Medication monitoring (implantable) | |
| 2. Calculation of drug injection volume | ||
| 3. Companion diagnosis | ||
| 4. Use in combination therapy, etc. | ||
| H. Other purposes | 1. Drug addiction rehabilitation | |
| 2. Others | ||
| I. Convergence products | N. Number the main purpose of use |
DMPA Product Code Technology Type
The third to fifth characters for digital medical devices shall be recorded sequentially from “A” to “E” according to the types of digital technologies in the device.
If only one digital technology is used, the fourth and fifth characters shall be marked as “X”. If only two digital technologies apply, the fifth character shall be marked as “X”. If four or more digital technologies apply, the fifth character shall be marked as “P”.
Technology | Third Character (Alphabet Capital) | Fourth Character (Alphabet Capital) | Fifth Character (Alphabet Capital) |
| Describe the digital technologies which apply sequentially from A |
| ||
A: Standalone software technology B: Artificial intelligence technology C: Intelligent robot technology D: Ultra-high performance computing technology E: Virtual/fusion technology X: If only one or two digital technologies apply, leave the remaining fields blank. P: If 4 or more technologies apply | |||
DMPA Product Code Product Form
The sixth character for digital medical devices shall be assigned based on the fundamental digital technology, and the seventh character is assigned according to the form of the digital medical device.
Product form | Sixth Character (Alphabet Capital) | Seventh Character (number) |
| A. Medical Devices B. In Vitro Diagnostic Medical Devices C. Both Medical Device and IVD (A+B) | 1. Standalone digital medical device software 2. Software-embedded digital medical device 3. Fusion (1+2) |
Concluding Remarks
With the separation of software medical devices (SaMD and SiMD) under the Medical Device Act and In Vitro Diagnostic Medical Device Act, the compliance of digital medical products has become significantly more complex and challenging.
Based on Emergo’s expert’s experience, we can provide professional assistance with assigning the appropriate seven character product code. The product code is one critical step in the registration process. Our next feature will discuss classification and then subsequently, the submission of regulatory documents.
Request more information from our specialists
Thanks for your interest in our products and services. Let's collect some information so we can connect you with the right person.